Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SCCE vs WELL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SCCE
Sachem Capital Corp. 6.00% Note

REIT - Industrial

Real EstateAMEX • US
Market Cap$1.14B
5Y Perf.-3.1%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+121.6%

SCCE vs WELL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SCCE logoSCCE
WELL logoWELL
IndustryREIT - IndustrialREIT - Healthcare Facilities
Market Cap$1.14B$149.25B
Revenue (TTM)$-13M$11.63B
Net Income (TTM)$4M$1.43B
Gross Margin39.1%
Operating Margin4.4%
Forward P/E598.3x78.4x
Total Debt$0.00$21.38B
Cash & Equiv.$11M$5.03B

SCCE vs WELLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SCCE
WELL
StockMar 22May 26Return
Sachem Capital Corp… (SCCE)10096.9-3.1%
Welltower Inc. (WELL)100221.6+121.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: SCCE vs WELL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 5 of 6 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Sachem Capital Corp. 6.00% Note is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
SCCE
Sachem Capital Corp. 6.00% Note
The Real Estate Income Play

SCCE is the clearest fit if your priority is growth exposure.

  • Rev growth 100.0%, EPS growth 104.3%
  • 100.0% FFO/revenue growth vs WELL's 35.8%
Best for: growth exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.13, yield 1.3%
  • 223.1% 10Y total return vs SCCE's 28.9%
  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSCCE logoSCCE100.0% FFO/revenue growth vs WELL's 35.8%
ValueWELL logoWELLLower P/E (78.4x vs 598.3x)
Stability / SafetyWELL logoWELLBeta 0.13 vs SCCE's 0.69
DividendsWELL logoWELL1.3% yield, 2-year raise streak, vs SCCE's 0.8%
Momentum (1Y)WELL logoWELL+42.7% vs SCCE's +34.8%
Efficiency (ROA)WELL logoWELL2.3% ROA vs SCCE's 0.8%

SCCE vs WELL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SCCESachem Capital Corp. 6.00% Note

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M

SCCE vs WELL — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGSCCE

Income & Cash Flow (Last 12 Months)

WELL leads this category, winning 2 of 2 comparable metrics.

WELL and SCCE operate at a comparable scale, with $11.6B and -$13M in trailing revenue. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
RevenueTrailing 12 months-$13M$11.6B
EBITDAEarnings before interest/tax$551,999$2.8B
Net IncomeAfter-tax profit$4M$1.4B
Free Cash FlowCash after capex$3M$2.5B
Gross MarginGross profit ÷ Revenue+39.1%
Operating MarginEBIT ÷ Revenue+4.4%
Net MarginNet income ÷ Revenue+12.3%
FCF MarginFCF ÷ Revenue+21.9%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%+40.3%
EPS Growth (YoY)Latest quarter vs prior year-81.9%+22.5%
WELL leads this category, winning 2 of 2 comparable metrics.

Valuation Metrics

WELL leads this category, winning 3 of 3 comparable metrics.

At 153.3x trailing earnings, WELL trades at a 74% valuation discount to SCCE's 598.3x P/E.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
Market CapShares × price$1.1B$149.2B
Enterprise ValueMkt cap + debt − cash$1.1B$165.6B
Trailing P/EPrice ÷ TTM EPS598.25x153.25x
Forward P/EPrice ÷ next-FY EPS est.78.42x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.40x
Price / SalesMarket cap ÷ Revenue13.99x
Price / BookPrice ÷ Book value/share6.41x3.35x
Price / FCFMarket cap ÷ FCF456.44x52.41x
WELL leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 3 of 5 comparable metrics.

WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $2 for SCCE. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SCCE's 5/9, reflecting strong financial health.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
ROE (TTM)Return on equity+2.3%+3.5%
ROA (TTM)Return on assets+0.8%+2.3%
ROICReturn on invested capital+0.5%
ROCEReturn on capital employed+0.6%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.49x
Net DebtTotal debt minus cash-$11M$16.3B
Cash & Equiv.Liquid assets$11M$5.0B
Total DebtShort + long-term debt$0$21.4B
Interest CoverageEBIT ÷ Interest expense0.26x
WELL leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $12,886 for SCCE. Over the past 12 months, WELL leads with a +42.7% total return vs SCCE's +34.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs SCCE's 13.7% — a key indicator of consistent wealth creation.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
YTD ReturnYear-to-date+4.7%+14.3%
1-Year ReturnPast 12 months+34.8%+42.7%
3-Year ReturnCumulative with dividends+46.8%+189.5%
5-Year ReturnCumulative with dividends+28.9%+202.3%
10-Year ReturnCumulative with dividends+28.9%+223.1%
CAGR (3Y)Annualised 3-year return+13.7%+42.5%
WELL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SCCE and WELL each lead in 1 of 2 comparable metrics.

WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than SCCE's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
Beta (5Y)Sensitivity to S&P 5000.69x0.13x
52-Week HighHighest price in past year$24.59$219.59
52-Week LowLowest price in past year$11.14$142.65
% of 52W HighCurrent price vs 52-week peak+97.3%+97.0%
RSI (14)Momentum oscillator 0–10060.160.2
Avg Volume (50D)Average daily shares traded5K2.6M
Evenly matched — SCCE and WELL each lead in 1 of 2 comparable metrics.

Analyst Outlook

WELL leads this category, winning 2 of 2 comparable metrics.

For income investors, WELL offers the higher dividend yield at 1.30% vs SCCE's 0.85%.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$226.50
# AnalystsCovering analysts34
Dividend YieldAnnual dividend ÷ price+0.8%+1.3%
Dividend StreakConsecutive years of raises02
Dividend / ShareAnnual DPS$0.20$2.76
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
WELL leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

WELL leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallWelltower Inc. (WELL)Leads 5 of 6 categories
Loading custom metrics...

SCCE vs WELL: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is SCCE or WELL a better buy right now?

For growth investors, Sachem Capital Corp.

6. 00% Note (SCCE) is the stronger pick with 100. 0% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SCCE or WELL?

On trailing P/E, Welltower Inc.

(WELL) is the cheapest at 153. 3x versus Sachem Capital Corp. 6. 00% Note at 598. 3x.

03

Which is the better long-term investment — SCCE or WELL?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to +28. 9% for Sachem Capital Corp. 6. 00% Note (SCCE). Over 10 years, the gap is even starker: WELL returned +223. 1% versus SCCE's +28. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SCCE or WELL?

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus Sachem Capital Corp. 6. 00% Note's 0. 69β — meaning SCCE is approximately 417% more volatile than WELL relative to the S&P 500.

05

Which is growing faster — SCCE or WELL?

By revenue growth (latest reported year), Sachem Capital Corp.

6. 00% Note (SCCE) is pulling ahead at 100. 0% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: Sachem Capital Corp. 6. 00% Note grew EPS 104. 3% year-over-year, compared to -11. 5% for Welltower Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SCCE or WELL?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus 0. 0% for Sachem Capital Corp. 6. 00% Note — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus 0. 0% for SCCE. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — SCCE or WELL?

All stocks in this comparison pay dividends.

Welltower Inc. (WELL) offers the highest yield at 1. 3%, versus 0. 8% for Sachem Capital Corp. 6. 00% Note (SCCE).

08

Is SCCE or WELL better for a retirement portfolio?

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, SCCE: +28. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between SCCE and WELL?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SCCE

Stable Dividend Mega-Cap

  • Sector: Real Estate
  • Market Cap > $100B
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SCCE and WELL on the metrics below

Revenue Growth>
%
(SCCE: -256.5% · WELL: 40.3%)
P/E Ratio<
x
(SCCE: 598.3x · WELL: 153.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.